CLEC12A and acute myeloid leukemia: CD123 has been identified as being consistently expressed in LSCs from 16 out of 18 AML patients, being notably absent in normal HSCs [18]; CD371 expression was detected in LSCs from 68 out of 74 AML samples [19].